InspireMD, Inc.
NSPR· Nasdaq
NSPRInspireMD, Inc.
Released Aug 5, 2020, before the open
10-Q filed Aug 5, 2020, 36 days after period end · 0001493152-20-014677
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $313.00K | $1.35M | $1.00M | $640.00K |
| Net Income | -$2.48M | -$2.21M | -$627.00K | -$2.29M |
| EPS Diluted |
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
| -$2.93 |
| -$1.59 |
| -$7.66 |
| -$7.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
